Novo Nordisk Q1 2024 Investor Presentation

Novo Nordisk's Q1 2024 investor presentation covering strategic aspirations, financial performance, innovation initiatives, and commercial execution. The deck highlights the company's focused healthcare approach and progress across its diabetes and obesity treatment portfolios.